By Sherri Oslick --
About
Court Report: Each week we will report briefly on recently filed
biotech and pharma cases, and a few interesting cases will be selected
for periodic monitoring.
UCB Inc. et al. v. KV Pharmaceutical Co.
1:08-cv-00223; filed April 18, 2008 in the District Court of Delaware
Infringement of U.S. Patent No. 6,344,215 ("Methylphenidate Modified Release Formulations," issued February 5, 2005) following a paragraph IV certification as part of KV's filing of an ANDA to manufacture a generic version of UCB's Metadate CD® (methylphenidate hydrochloride, used to treat attention deficit hyperactivity disorder). View the complaint here.
Connetics Corp. et al. v. Pentech Pharmaceuticals Inc.
1:08-cv-02230; filed April 18, 2008 in the Northern District of Illinois
Infringement of U.S. Patent No. 6,126,920 ("Method of Treating a Skin Disease with a Corticosteroidcontaining Pharmaceutical Composition," issued October 3, 2000) following a paragraph IV certification as part of Pentech's filing of an ANDA to manufacture a generic version of Connectics' OLUX® (clobetasol propionate foam 0.05%, used to treat moderate to severe scalp dermatoses). View the complaint here.
McNeil-PPC, Inc. v. Perrigo Co. et al.
3:08-cv-01909; filed April 18, 2008 in the District Court of New Jersey
Infringement of U.S. Patent No. 6,153,635 ("Methods and Kits for Treating Vulvovaginal Candidiasis with Miconazole Nitrate," issued November 28, 2000) following a paragraph IV certification as part of Perrigo's filing of an ANDA to manufacture a generic version of McNeil's Monistat® 1 Combination Pack (miconazole nitrate vaginal cream and suppository, used to treat vaginal yeast infections). View the complaint here.
Bayer Schering Pharma AG et al. v. Sandoz, Inc. et al.
1:08-cv-03710; filed April 18, 2008 in the Southern District of New York
Infringement of U.S. Patent No. 5,569,652 ("Dihydrospirorenone as an Antiandrogen," issued October 29, 1996) following a paragraph IV certification as part of Sandoz's filing of an ANDA to manufacture a generic version of Bayer's Yasmin® (drospirenone and ethinyl estradiol, used as oral contraception). View the complaint here.
Comments